These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Piperacetazine in ambulatory chronic schizophrenic patients. Rada RT; Donlon PT Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665 [No Abstract] [Full Text] [Related]
6. Sex and race differences in response to drug treatment among schizophrenics. Goldberg SC; Schooler NR; Davidson EM; Kayce MM Psychopharmacologia; 1966; 9(1):31-47. PubMed ID: 5989102 [No Abstract] [Full Text] [Related]
7. [Pilot study on oxaflumazine, a new piperazinated phenothiazine]. Villeneuve A; Dogan K; Lachance R; Drolet A Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378 [No Abstract] [Full Text] [Related]
8. Phenothiazines and diffuse melanosis. Greiner AC Agressologie; 1968; 9(2):219-24. PubMed ID: 5675489 [No Abstract] [Full Text] [Related]
9. Central atropine-like toxicity in combined psychotropic drug administration. el-Yousef MK; Davis JM; Janowsky DS; Fann WE J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620 [No Abstract] [Full Text] [Related]
10. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population. Martin IC Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189 [TBL] [Abstract][Full Text] [Related]
11. [Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy]. Volkov VP Klin Med (Mosk); 2011; 89(4):27-30. PubMed ID: 21932558 [TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia in schizophrenic outpatients. Kok LP; Christopher YS Ann Acad Med Singap; 1985 Jan; 14(1):87-90. PubMed ID: 2860841 [TBL] [Abstract][Full Text] [Related]
13. Important issues in the drug treatment of schizophrenia. Davis JM; Schaffer CB; Killian GA; Kinard C; Chan C Schizophr Bull; 1980; 6(1):70-87. PubMed ID: 6102795 [TBL] [Abstract][Full Text] [Related]
15. Potential value of penfluridol and pipothiazine palmitate. Gallant DM Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769 [No Abstract] [Full Text] [Related]
16. A preliminary approach to the problems of relating the pharmacokinetics of phenothiazines to clinical response with schizophrenic patients [proceedings]. Gottschalk LA Psychopharmacol Bull; 1978 Jul; 14(3):35-9. PubMed ID: 27839 [No Abstract] [Full Text] [Related]
17. A comparison of phenothiazines in managing aggressive episodes in schizophrenic patients. Simeon J; Wadud A; Itil T Hosp Community Psychiatry; 1975 Sep; 26(9):574. PubMed ID: 238907 [No Abstract] [Full Text] [Related]
18. The effect of rubidium in schizophrenia. Chouinard G; Annable L Commun Psychopharmacol; 1977; 1(4):373-83. PubMed ID: 28202 [No Abstract] [Full Text] [Related]
19. Implications of drug treatment for the social rehabilitation of schizophrenic patients. Engelhardt DM; Rosen B Schizophr Bull; 1976; 2(3):454-62. PubMed ID: 12559 [No Abstract] [Full Text] [Related]
20. Pigmentation due to phenothiazines in high and prolonged dosage. Satanove A JAMA; 1965 Jan; 191(4):263-8. PubMed ID: 5899740 [No Abstract] [Full Text] [Related] [Next] [New Search]